• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒5型12S生长因子诱导F9细胞增殖和分化。

The Ad5 12S growth factor induces F9 cell proliferation and differentiation.

作者信息

Quinlan M P

机构信息

Cold Spring Harbor Laboratory, New York 11724.

出版信息

Oncogene. 1989 Aug;4(8):1051-5.

PMID:2569707
Abstract

The 12S gene of the E1A region of adenovirus induces the production of a growth factor that is necessary for the immortalization of primary epithelial cells. This growth factor is able to replace the strict serum requirement of F9 cells, a teratocarcinoma-derived embryonal carcinoma cell line. Furthermore, the growth factor induces a morphological alteration in the F9 cells such that they resemble visceral endoderm cells and express the surface antigens, SSEA-1 and SSEA-3, characteristic of these differentiated cells.

摘要

腺病毒E1A区域的12S基因诱导产生一种生长因子,该生长因子是原代上皮细胞永生化所必需的。这种生长因子能够替代F9细胞(一种源自畸胎癌的胚胎癌细胞系)对血清的严格需求。此外,该生长因子会诱导F9细胞发生形态改变,使其类似于脏内胚层细胞,并表达这些分化细胞特有的表面抗原SSEA-1和SSEA-3。

相似文献

1
The Ad5 12S growth factor induces F9 cell proliferation and differentiation.腺病毒5型12S生长因子诱导F9细胞增殖和分化。
Oncogene. 1989 Aug;4(8):1051-5.
2
The adenovirus Ela gene induces differentiation of F9 teratocarcinoma cells.腺病毒Ela基因诱导F9畸胎瘤细胞分化。
Mol Cell Biol. 1987 May;7(5):1782-90. doi: 10.1128/mcb.7.5.1782-1790.1987.
3
[The surface glycolipid antigen specific for the internal cell mass of the mouse blastocyst and of the stem cells of murine teratocarcinoma F9].[针对小鼠囊胚内细胞团和鼠畸胎瘤F9干细胞的表面糖脂抗原]
Ontogenez. 1989 Mar-Apr;20(2):158-63.
4
Organ colonization pattern of retinoic acid-treated and -untreated mouse embryonal carcinoma F9 cells.
Cancer Res. 1987 Jul 15;47(14):3791-7.
5
Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.胚胎癌细胞来源的内胚层样细胞产生胰岛素样生长因子-II(MSA):可能是胚胎细胞生长的介质。
J Cell Physiol. 1985 Aug;124(2):199-206. doi: 10.1002/jcp.1041240205.
6
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.睾丸生殖细胞肿瘤中畸胎癌衍生生长因子-1(TDGF-1)的表达及其对胚胎癌细胞系NTERA2/D1生长和分化的影响。
Oncogene. 1997 Aug 18;15(8):927-36. doi: 10.1038/sj.onc.1201260.
7
Efficient nuclear localization of the Ad5 E1A 12S protein is necessary for immortalization but not cotransformation of primary epithelial cells.
Cell Growth Differ. 1994 May;5(5):475-83.
8
Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.胚胎癌细胞通过对应于原始内胚层的中间阶段分化为滋养层内胚层。
In Vivo. 1994 Nov-Dec;8(6):967-73.
9
The effects of laminin on the growth and differentiation of embryonal carcinoma cells in defined media.
J Supramol Struct. 1980;13(2):243-53. doi: 10.1002/jss.400130212.
10
Carbohydrate antigens of embryonal carcinoma cells: changes upon differentiation.胚胎癌细胞的碳水化合物抗原:分化过程中的变化
APMIS Suppl. 1992;27:109-18.

引用本文的文献

1
Functional specificity of ras isoforms: so similar but so different.Ras 同工型的功能特异性:如此相似却又如此不同。
Genes Cancer. 2011 Mar;2(3):216-31. doi: 10.1177/1947601911408081.
2
E1a-dependent expression of adenovirus genes in OTF963 embryonal carcinoma cells: role of E1a-induced differentiation.腺病毒基因在OTF963胚胎癌细胞中E1a依赖性表达:E1a诱导分化的作用
Proc Natl Acad Sci U S A. 1990 Oct;87(20):8041-5. doi: 10.1073/pnas.87.20.8041.
3
Expression and interactions of human adenovirus oncoproteins.人类腺病毒癌蛋白的表达与相互作用。
Biochem J. 1991 Apr 15;275 ( Pt 2)(Pt 2):281-99. doi: 10.1042/bj2750281.
4
Immortalization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S.原代上皮细胞的永生化需要5型腺病毒12S的第一外显子和第二外显子功能。
J Virol. 1992 Apr;66(4):2020-30. doi: 10.1128/JVI.66.4.2020-2030.1992.